KZR
Kezar Life Sciences (KZR)
$15
About Kezar Life Sciences (KZR)
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.
Details
Daily high
$6.24
Daily low
$6.15
Price at open
$6.15
52 Week High
$6.65
52 Week Low
$3.53
Market cap
45.3M
Dividend yield
0.00%
Volume
31,848
Avg. volume
30,717
P/E ratio
-.73
Kezar Life Sciences News
Details
Daily high
$6.24
Daily low
$6.15
Price at open
$6.15
52 Week High
$6.65
52 Week Low
$3.53
Market cap
45.3M
Dividend yield
0.00%
Volume
31,848
Avg. volume
30,717
P/E ratio
-.73